Thomas Siebel, the patriarch and founder, recently withdrew from his duties as CEO, citing health concerns. His absence, much like the departure of a seasoned dowager from a bustling drawing room, has left a palpable void. For Mr. Siebel was not merely an overseer but an active participant in the delicate art of deal-making-a role that, when relinquished, inevitably disrupts the harmony of commerce.
But as with all good things, there’s a pesky little hiccup-a U.S. antitrust lawsuit that’s been hanging over Alphabet like an uninvited relative at Thanksgiving dinner. Last year, a judge ruled that Alphabet had a monopoly over Internet search. You know, the whole “we own Google Search, and everyone else can just… well, Google something else” thing. The Justice Department suggested a breakup, which would have included selling off Google Chrome. Talk about breaking up the band, right? Imagine losing your lead singer and guitarist at the same time.
There is a quiet, methodical compression occurring in Bitcoin’s returns-a statistical bureaucracy that reduces peak multiples with the efficiency of a machine. Each four-year halving, that inescapable ritual, halves the supply of new coins, yet the system’s logic remains unyielding. The asset’s integration into the traditional financial sector, via ETFs, has added a new layer of procedural complexity: a labyrinth of inflows, outflows, and institutional custodianship that obfuscates the original thesis. The question, then, is not whether it is too late to buy, but whether one can navigate the bureaucratic maze without succumbing to its absurdities.
LET ME TELL YOU ABOUT HUMIRA, THAT LUCRATIVE GHOST THAT WALKED INTO THE PATENT CLIFF AND CAME OUT WITH A BONUS. ABBVIE SPUN OFF IN 2013 LIKE A BLOOD-SUCKING VAMPIRE, LEAVING ABBOTT TO DEAL WITH THE CARNAGE. BUT HERE’S THE TRICK: THEY STACKED PATENTS LIKE BRICKS IN A TOWER, HOLDING OFF BIOSIMILARS UNTIL 2023. IT WASN’T JUST A PATENT-IT WAS A GODDAMN WALL OF LEGAL FEAR.
Investors, like ants in a sugar factory, have followed Buffett’s trail of crumbs, mistaking his occasional musings for a map. But the true nature of his strategy remains obscured, a bureaucratic riddle wrapped in a parable. The four words he scribbled in Berkshire’s latest shareholder letter-“Often, nothing looks compelling”-are not a confession of failure but a bureaucratic directive: Proceed with caution; the forms are incomplete.
Dons, routes, babioles, mais voici le florilège des grandes mises en garde. Treize sont donc ceux qui, sans crier gare, agrandissent ce fabuleux jardin de Solana, fort de près de neuf millions de SOL, et quelle ironie il se mêlerait de représenter le sourire de mille et une nuits à 1.55 % du tout ce tremble de SOL en circulation – ce qui nous donne, pour le dire sans soupirer, la rondelette somme de $1.8 milliards.
Opendoor, as an iBuyer, operates through a system of instant cash offers for homes, followed by repairs and relisting on its own platform. Its pricing is dictated by algorithms of such opacity that even its creators might struggle to decipher their logic. During periods of low interest rates, its operations thrived, and the post-pandemic housing boom of late 2020 and 2021 saw a surge in activity. Yet this prosperity was fleeting, as rising interest rates in 2022 and 2023 cast a shadow over the market, forcing competitors like Zillow and Redfin to abandon their iBuying ventures, leaving Opendoor as the sole custodian of this peculiar domain.
Today, Amex gifts shareholders $0.82 per share each quarter-a 1% yield, modest as a mouse’s whisker but reliable as the moon’s pull on the tides. It doesn’t splash about with annual raises, no, but it tiptoes upward, like a thief in a pinstripe suit. By 2025, Berkshire will pocket $479 million in dividends-nearly 37% of its original wager. One might call it a heist. Or a very polite robbery.
Let’s take a closer look at its results and prospects to see if the stock can come back in fashion-or if it’s merely a case of the market’s alchemists failing to turn lead into gold.
Yet these are but the surface cracks. The true fissure lies in the company’s soul, where the gears of innovation grind against the bones of its core business. The Master Plan Part 4, a manifesto of grand visions, casts a cold eye on the very engines that built Tesla’s empire. Electric vehicles, once its beating heart, are reduced to a footnote. Solar roofs, battery storage-forgotten whispers. Instead, the plan orbits around autonomous dreams, AI, and the gleam of humanoid machines.